Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1980 • 4,703 citations

The effect of ABO blood group on the diagnosis of von Willebrand disease

1987 • 898 citations

Pathogenesis of systemic sclerosis: A vascular hypothesis

1975 • 412 citations

Increased Factor VIII/von Willebrand Factor Antigen and von Willebrand Factor Activity in Scleroderma and in Raynaud's Phenomenon

1981 • 220 citations

A RELIABLE MARKER OF ENDOTHELIAL CELL DYSFUNCTION: DOES IT EXIST?

1995 • 216 citations

Tissue Plasminogen Activator: Chemical and Physiological Aspects

1984 • 210 citations

Elevated Levels of Circulating Platelet Aggregates and Beta-Thromboglobulin in Scleroderma

1982 • 123 citations

The Effects of Acute Smoking on Platelet Behaviour, Fibrinolysis and Haemorheology in Habitual Smokers

1984 • 122 citations

Adverse Influence of Cigarette Smoking on the Endothelium

1993 • 119 citations

Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon.

1993 • 116 citations

Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.

1986 • 89 citations

Plasma Thrombomodulin as a Marker of Vascular Injuries in Collagen Vascular Diseases

1994 • 83 citations

Vascular damage and factor-VIII-related antigen in the rheumatic diseases

1987 • 81 citations

Assessment of platelet function in patients with Raynaud's syndrome.

1984 • 67 citations

ELEVATED von WILLEBRAND FACTOR ANTIGEN IN SYSTEMIC SCLEROSIS: RELATIONSHIP TO VISCERAL DISEASE

1988 • 54 citations

Abnormal fibrinolysis in healthy male cigarette smokers: Role of plasminogen activator inhibitors

1989 • 47 citations

Cigarette Smoking Increases Thromboxane A2 Formation without Affecting Platelet Survival in Young Healthy Females

1992 • 39 citations

Tissue-type plasminogen activator and von Willebrand factor plasma levels as markers of endothelial involvement in patients with Raynaud's phenomenon.

1992 • 39 citations

Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis.

1991 • 39 citations

Platelet activation, fibrinolytic activity and circulating immune complexes in Raynaud's phenomenon.

1982 • 37 citations

Plasma and Serum Von Willebrand Factor Antigen Concentrations in Connective Tissue Disorders

1992 • 36 citations

Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.

1985 • 35 citations

Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis

1993 • 34 citations

Reduced angiotensin converting enzyme plasma activity in scleroderma. A marker of endothelial injury?

1990 • 29 citations

Supranormal von Willebrand factor multimers in scleroderma

1989 • 28 citations

The clinical significance of coagulation abnormalities in systemic sclerosis (scleroderma).

1985 • 24 citations

FACTOR VIII RELATED ANTIGEN IN CONNECTIVE TISSUE DISEASE PATIENTS AND RELATIVES

1990 • 24 citations

Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.

1993 • 24 citations

Supranormal von Willebrand factor multimers in scleroderma

1989 • 21 citations

Enhanced platelet adhesion to collagen in scleroderma. Effect of scleroderma plasma and scleroderma platelets.

1985 • 19 citations

Progressive Systemic Sclerosis

1985 • 5 citations

Deleted Work

1955 • 0 citations